Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma
Clinical trial NCT00369681 · COMPLETED
Trial details
- NCT number
- NCT00369681
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2014-10-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.